![](https://d3ilqtpdwi981i.cloudfront.net/yNM1w8hBHU2Pwq9NUksy520iBsY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/9c/f7/7d/9cf77d1e-0f63-4f1c-b323-0c0a2e2127b4/thumbnail_c10bbc95-abb3-4a67-a7fb-eb28e421b497.jpg)
A natural product chemistry-based approach was applied to discover small-molecule inhibitors of hypoxia-inducible factor-1 (HIF-1). A Petrosaspongia mycofijiensis marine sponge extract yielded mycothiazole (1), a solid tumor selective compound with no known mechanism for its cell line-dependent cytotoxic activity. Compound 1 inhibited hypoxic HIF-1 signaling in tumor cells (IC(50) 1nM) that correlated with the suppression of hypoxia-stimulated tumor angiogenesis in vitro. However, 1 exhibited pronounced neurotoxicity in vitro. Mechanistic studies revealed that 1 selectively suppresses mitochondrial respiration at complex I (NADH-ubiquinone oxidoreductase). Unlike rotenone, MPP(+), annonaceous acetogenins, piericidin A, and other complex I inhibitors, mycothiazole is a mixed polyketide/peptide-derived compound with a central thiazole moiety. The exquisite potency and structural novelty of 1 suggest that it may serve as a valuable molecular probe for mitochondrial biology and HIF-mediated hypoxic signaling.
Available at: http://works.bepress.com/tyler-a-johnson/12/